Continuation treatment of major depressive disorder: is there a case for duloxetine?
Open Access
- 1 February 2010
- journal article
- review article
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. 4, 19-31
- https://doi.org/10.2147/dddt.s4358
Abstract
Peer reviewed article authored by (Trevor R Norman, James S Olver). Read article or submit your manuscript for publishing.Keywords
This publication has 53 references indexed in Scilit:
- The General and Comparative Efficacy and Safety of Duloxetine in Major Depressive DisorderDrug Safety, 2009
- Treatment-Emergent Sexual Dysfunction Related to AntidepressantsJournal of Clinical Psychopharmacology, 2009
- Duloxetine in the Prevention of Depressive RecurrencesThe Journal of Clinical Psychiatry, 2009
- Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75–225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT studyInternational Clinical Psychopharmacology, 2008
- Duloxetine and suicide attempts: a possible relationClinical Practice and Epidemiology in Mental Health, 2008
- Changes in Sexual Functioning Associated with Duloxetine, Escitalopram, and Placebo in the Treatment of Patients with Major Depressive DisorderThe Journal of Sexual Medicine, 2007
- A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorderCurrent Medical Research and Opinion, 2007
- DuloxetineJournal of Clinical Psychopharmacology, 2006
- The Medical Management of DepressionNew England Journal of Medicine, 2005
- Older community residents with depression: long-term treatment with sertralineThe British Journal of Psychiatry, 2003